Taigen Biotech, ScinoPharm Collaborate On New Stem-Cell Drug
This article was originally published in PharmAsia News
Executive Summary
TaiGen Biotechnology has joined forces with ScinoPharm Taiwan to have it produce its active pharmaceutical ingredient for TaiGen's TG0054 (burixafor) stem cell mobilizer drug.